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Introduction
Doppler velocity measurement has been extensively ap-
plied in prenatal diagnosis for more than two decades.
Blood flow in numerous vessels has been investigated
to predict fetal condition, especially in the umbilical
artery [1–7]. Histopathologic studies suggest that ab-
normal umbilical artery Doppler velocimetry is correlated
with a pathologic lesion of the placenta characterized
by obliteration of arterioles in the tertiary stem villi; the
umbilical artery flow velocity waveform is primarily de-
termined by placental villous vascular architecture [8,9].
The increased placental vascular resistance is reflected
as a decreased diastolic phase of the umbilical artery
waveform; moreover, end-diastolic flow of the umbilical
artery vanishes and ultimately reverses in the progres-
sively worsened condition, and absent or reversed end-
diastolic velocity (AREDV) flow is finally present in the
Doppler waveform [3,4,10,11]. AREDV during preg-
nancy is a strong indication of placental insufficiency.
Previous studies have clarified that an increased um-
bilical artery systolic/diastolic ratio is a significant risk
factor for progression of fetal acidosis, fetal distress,
preterm delivery, low Apgar scores, and even perinatal
death [12–15]. Mortality and morbidity (such as intra-
ventricular hemorrhage [IVH], periventricular leukoma-
lacia [PVL], bronchopulmonary dysplasia [BPD],
respiratory distress syndrome [RDS], necrotizing entero-
colitis [NEC], and long-term neurodevelopmental im-
pairment) of fetuses with AREDV in the umbilical artery
have been well discussed, especially in growth-restricted
fetuses [1,2,10,16,17]. When AREDV occurs prenatally,
close follow-up or expeditious delivery should be consid-
ered. High-risk pregnancies, such as preeclampsia and
intrauterine growth restriction (IUGR), have abnormal
development of the placenta vasculature which can be
revealed in the abnormal Doppler velocimetry [9,18].
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We reviewed articles of neonatal complications related
to abnormal umbilical artery Doppler ultrasonography.
Intraventricular Hemorrhage
IVH is an important cause of morbidity and mortality
in very low-birth-weight infants, and high-grade IVH is
a significant risk factor for severe perceptual, cognitive
and motor neurologic impairment [19]. AREDV in the
umbilical artery causes an enhanced right ventricular
afterload which induces greater output to the left ven-
tricle (redistribution of fetal blood flow) and increases
cerebral perfusion [20,21]. In this condition, cerebral
vasodilatation increases vascular wall strain and me-
chanical forces, which may contribute to IVH. On the
other hand, AREDV in the umbilical artery also causes
fetal hypoxia, acidemia, platelet depletion, and elevated
nucleated red blood cells; this may cause hemorrhagic
placental endovasculitis, infarction, and may subse-
quently increase the risk of brain injury [22–25]. Eronen
et al [26] prospectively studied the flow velocities of the
umbilical artery, descending aorta and aortic arch of
65 pregnant women with gestational hypertension be-
tween 24 and 34 gestational weeks, and 42 live-born
infants (23 with and 19 without AREDV) were analyzed.
They found that neonates with AREDV had an increased
incidence of IVH (p = 0.03). Gaziano et al [27] observed
the relationship between umbilical artery Doppler velo-
cimetry and neonatal outcomes in 90 surviving neonates
out of 100 IUGR infants, and found that the incidence
of IVH (20% vs. 6%) was higher in the abnormal Doppler
group (mean systolic/diastolic ratio ≥ 2 SD) (p = 0.05).
Yoon et al [28] performed a study of umbilical artery
velocimetry in 72 pregnant women with preeclampsia
and found that women with abnormal umbilical artery
velocimetry (pulsatility index > 2 SD) had a significantly
higher incidence of IVH (p < 0.05). Karsdorp et al [29]
assessed the outcome of antenatal umbilical artery
Doppler velocimetry in three groups: 214 children with
forward end-diastolic velocity (FEDV), 178 with absent
end-diastolic velocity (AEDV), and 67 with reversed end-
diastolic velocity (REDV); they also found an increased
incidence of IVH in the AREDV group (p = 0.02). More
recently, Baschat et al [30] evaluated the relationship
between neonatal IVH and Doppler flow in 113 IUGR
fetuses, of whom 15 (13.3%) had IVH, and 51 (45.1%)
had umbilical artery AREDV; the relative risk was 4.9-
fold greater for IVH in subjects with AREDV. In contrast,
several studies demonstrated that when the effects of
prematurity and IUGR were considered, AREDV in the
umbilical artery appeared to be a poor indicator of
IVH [31,32].
Periventricular Leukomalacia
PVL is the most important determinant of neurologic
morbidity in children who are born prematurely and is
considered a sonographic marker for cerebral palsy
[33,34]. Unlike IVH, however, studies discussing the rela-
tionship between umbilical artery AREDV and PVL are
limited, and several studies failed to find an association
between AREDV and PVL [17,32]. In theory, blood–gas
analyses from cordocentesis or immediately after birth
have found a strong correlation between AREDV and
acidemia in IUGR fetuses [23]; moreover, studies of
preterm fetal and newborn metabolic acidosis also sug-
gested a higher risk of severe PVL [35]. Further large
prospective studies are necessary to verify the impact
of AREDV in PVL, since it is an important predictor of
neurodevelopmental impairment.
Bronchopulmonary Dysplasia
BPD is one of the most common respiratory complica-
tions in premature infants. The predisposing factors for
BPD include lung immaturity, airway inflammation, peri-
natal infection, oxygen toxicity, and barotrauma result-
ing from mechanical ventilation [36–38]. Furthermore,
BPD is a significant risk factor for neurodevelopmental
impairment [39,40]. Studies discussing the relationship
between umbilical artery AREDV and BPD are scanty;
nevertheless, a positive correlation has been found
[17,26]. Eronen et al [26] prospectively studied the flow
velocities of the umbilical artery, descending aorta and
aortic arch of 65 pregnant women with gestational
hypertension between 24 and 34 weeks’ gestation, and
42 live births (23 with and 19 without AREDV) were
analyzed. They found that neonates with AREDV had an
increased incidence of BPD (p=0.03). Hartung et al [17]
reviewed the outcomes of 60 neonates with AREDV flow
prenatally, of whom 44 (61%) survived, and they found
a statistically significant increase in BPD compared with
the control group (p = 0.002).
Respiratory Distress Syndrome
RDS is one of the leading causes of mortality and mor-
bidity among premature neonates. Despite findings in
numerous studies, the relationship between AREDV in
the umbilical artery and RDS is still controversial. Yoon
et al [28] performed a study of umbilical artery velocim-
etry in 72 pregnant women with preeclampsia and
found that women with abnormal umbilical artery velo-
cimetry (pulsatility index > 2 SD) had a significantly
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higher incidence of RDS (p < 0.01). Gonzalez et al [41]
performed a retrospective cohort study of 151 pregnan-
cies with IUGR, of which 24 cases had AREDV in the
umbilical artery (17 with AEDV and seven with REDV);
they found that an umbilical artery with AREDV in the
presence of IUGR was associated with a significantly
increased incidence of RDS (odds ratio, OR, 6.5; 95%
confidence interval, CI, 1.8–23.3). In contrast with pre-
vious studies, Karsdorp et al [29] assessed the outcome
of antenatal umbilical artery Doppler velocimetry in
three groups: 214 children with FEDV, 178 with AEDV,
and 67 with REDV. They found that umbilical artery
AREDV did not increase the risk of RDS. Hartung et al
[17] reviewed the outcomes of 60 neonates with AREDV
flow prenatally, of whom 44 survived (61%), and they
found that there was no statistically significant increase
in RDS compared with the control group. Torrance et al
[42] performed a retrospective study of umbilical artery
Doppler velocimetry in 187 IUGR infants before 30
weeks’ gestation. They found no significant increase in
incidence of RDS in the infants with abnormal umbilical
artery Doppler velocimetry, and concluded that lung
maturation is not related to placental insufficiency.
Necrotizing Enterocolitis
The pathogenesis of NEC is not well understood and
factors thought to increase the risk of intestinal injury
include prematurity, intestinal ischemia, enteral feed-
ing, and bacterial colonization [43,44]. Recent studies
have shown that IUGR may be an additional risk factor
of NEC [45–47]. In fetuses with AREDV in the umbilical
artery, especially combined with IUGR, circulatory redis-
tribution increases blood flow to the brain (the brain-
sparing effect) and decreases blood flow to the viscera.
Fetal hypoxia combines with increased mesenteric vas-
cular resistance to predispose to intestinal ischemic
injury; this may contribute to the development of NEC
[48]. Dorling et al [48] performed a meta-analysis of
14 case series between 1987 and 2002 to compare the
NEC rate in AREDV infants with controls and found that
nine studies reported a higher incidence of NEC in the
study groups, with an OR of 2.13 (95% CI, 1.49–3.03) in
all 14 studies. Hartung et al [17] reviewed the outcomes
of 60 neonates with AREDV flow prenatally, of whom
44 survived (61%) and were compared with the control
group. They found a statistically significant increase in
intestinal complications (NEC or operation; p < 0.01) in
the AREDV group. However, more recent studies found
contrasting results. Gonzalez et al [41] performed a
study of 151 pregnancies with IUGR over 7 years, of
which 24 had AREDV, and they found that there was
no significant association between AREDV and NEC
(OR, 1; 95% CI, 0.1–9.8). Manogura et al [49] prospec-
tively studied the umbilical artery, middle cerebral artery,
ductus venosus and umbilical vein flow of 404 neonates,
of whom 39 (9.7%) had NEC, and they found that the
neonates with NEC had higher placental resistance with
significantly increased umbilical artery pulsatility index
(4.91 vs. 4.17; p=0.023). Nevertheless, further advanced
analysis of placental resistance failed to demonstrate a
progressive relationship, and there was no significant
correlation between AEDV or REDV and NEC (p = 0.079
and 0.520). The authors analyzed their different out-
comes with some previous studies and pointed to: (1)
incomplete observations in previous studies because
of confined single arterial beds (umbilical or mesenteric
arteries), (2) underpowered studies because of the low
incidence of NEC, (3) missed determination of the rela-
tionship of abnormal Doppler progression and gesta-
tional age, and (4) metabolic status at birth not been
taken into account. They concluded that placental insuf-
ficiency may predispose patients to NEC but is not the
primary cascade of events leading to NEC.
Perinatal Mortality
According to our review, AREDV in the umbilical artery
is associated with IVH and BPD, and may be related to
RDS and NEC. IVH is a major risk factor for neonatal
death and, together with BPD, is an important compli-
cation in the very premature infant. Therefore, we would
expect to see an increased incidence of perinatal mor-
tality. This is supported by a number of studies. Eronen
et al [26] prospectively studied the flow velocities of
the umbilical artery, descending aorta and aortic arch
of 65 pregnant women with gestational hypertension
between 24 and 34 gestational weeks, and 42 live births
(23 with and 19 without AREDV) were analyzed. In con-
trast to no mortality in fetuses without AREDV, the mor-
tality rate with AREDV was 30% (p = 0.01). Yoon et al
[28] analyzed the umbilical artery velocimetry in 72
pregnant women complicated with preeclampsia and
found that women with an abnormal umbilical artery
velocimetry (pulsatility index > 2 SD) had a significantly
higher incidence of perinatal death (p < 0.000001).
Karsdorp et al [29] assessed the outcome of antenatal
umbilical artery Doppler velocimetry in three groups:
214 children with FEDV, 178 with AEDV, and 67 with
REDV; the OR for perinatal mortality in pregnancies
complicated by AEDV flow was 4.0 and by REDV flow
was 10.6, compared with the FEDV group. Valcamonico
et al [50] analyzed 20 surviving IUGR infants with ante-
natal AREDV in the umbilical artery and 26 IUGR
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infants with positive diastolic flow velocity, divided into
two control groups (10 with a normal Doppler pattern
and 16 with reduced but present end-diastolic flow).
They found an increased rate of perinatal mortality in
the AREDV group than in the two control groups (26%
vs. 6% and 4%). Our previous study [11] observed the
outcomes of 30 fetuses with REDV in the third trimester
and found three stillbirths and 12 neonatal deaths,
resulting in a perinatal mortality rate of 50%. More
recently, Spinillo et al [32] conducted a cohort study
of 582 neonates with gestational ages between 24 and
35 weeks and also found that the risk of neonatal
death was associated with increased umbilical artery
resistance in IUGR fetuses based on univariate strati-
fied analysis (p = 0.045).
Neurodevelopment
The association of umbilical artery Doppler velocime-
try and long-term neurodevelopmental outcome in
children is controversial. Two studies [51,52] failed to
demonstrate the relationship between abnormal umbil-
ical artery flow velocity waveforms and long-term neu-
rodevelopmental sequelae. Wilson et al [51] carried out
a study of 40 children with abnormal umbilical artery
flow velocity waveforms and followed their neurologic
development at 5 years of age, finding no significant
difference in neurologic impairment between normal
and abnormal waveform groups. Kirsten et al [52] per-
formed another umbilical artery Doppler study of 242
pregnant women with severe preeclampsia before 34
weeks’ gestation, of whom 68 (28%) had AEDV. They
followed 193 surviving infants at 6-monthly intervals
until 4 years of age, and concluded that there was no
difference in the developmental quotients and motor
outcomes between the infants with absent end-diastolic
velocities and those in the control groups. However,
other studies [32,50,53–55] have described an associa-
tion between AREDV in the umbilical artery and adverse
neurologic sequelae. Weiss et al [53] performed a study
to examine the neurologic outcome of 37 newborns with
antenatal AREDV in the umbilical artery, and found a
greater risk of neurologic sequelae during the first 6
months of age in infants with AREDV than in the con-
trol group (11 vs. 3). Valcamonico et al [50] studied
20 surviving IUGR infants with antenatal AREDV in the
umbilical artery and 26 IUGR infants with positive dia-
stolic flow velocity, divided into two control groups (10
with normal Doppler pattern and 16 with reduced but
present end-diastolic flow). They performed neurologic
examinations at 3, 6, 9, 12, 18 and 24 months of age
and found a higher incidence of permanent neurologic
sequelae in the study group than in the two control
groups (35% vs. 0% and 12%). Nevertheless, a recent
follow-up study over 8 years by the same authors re-
vealed no difference in the intelligence quotient between
the study group and the two control groups, and the
authors concluded that AREDV cannot be a reliable pre-
dictor of intellectual development at school age [56].
Vossbeck et al [54] performed another study to exam-
ine the neurodevelopmental outcome of 40 preterm
infants, under 30 weeks’ gestation, with umbilical artery
AREDV compared with 40 gestational age-matched con-
trols. The Kaufman Assessment Battery for Children or
the Bayley Scales of Infant Development was performed
at 13–100 months of age, and the authors found that
infants with AREDV had an increased risk of permanent
neurodevelopmental impairment compared with con-
trols: 44% vs. 25% had mental retardation (p = 0.033),
and 38% vs. 19% had severe motor impairment (p =
0.073). Schreuder et al [55] assessed 76 children at
5–12 years of age who had antenatal umbilical artery
Doppler measurements; 40 had FEDV, 27 had AEDV,
and nine had REDV. They found that the mental ability
and neuromotor function of the REDV group were worse
than those of either the FEDV or AEDV groups. Com-
paring REDV with the FDFV and AEDV groups, the
British Ability Scales general conceptual ability mean
scores were 87.7 vs. 101 and 101.1, respectively, and the
Quick Neurological Screening Test mean scores were
32.8 vs. 21.5 and 23.2, respectively. The authors sug-
gested that REDV, but not AEDV, represents intrauter-
ine decompensation and increases the risk of neurologic
sequelae. More recently, Spinillo et al [32] carried out
a cohort study of 582 neonates born between 24 and
35 weeks’ gestation, and evaluated the relationship be-
tween umbilical artery Doppler flow velocities and the
infants’ neurodevelopmental outcome at 2 years. Among
the 21 infants of IUGR, 13 cases of neonatal death or
cerebral palsy occurred in pregnancies with AREDV in
the umbilical artery (p = 0.01). The authors concluded
that AREDV in the umbilical artery is an independent
predictor of cerebral palsy or neonatal death in preterm
infants complicated by IUGR.
Previous animal models have reported that increased
placental impedance generates abnormally small brain
weight and results in delayed development [57–59].
Furthermore, the mechanisms and hypotheses of AREDV
predisposing to IVH may also result in long-term neu-
rologic damage [20–25]. One human study by Tolsa
et al [60] examined the cause of the relationship between
the severity of abnormal umbilical artery blood flow and
neurodevelopmental impairment in infants. The authors
used magnetic resonance imaging to measure brain tis-
sue volumes in 14 premature infants with placental
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insufficiency (indicated by abnormal Doppler mea-
surements) and IUGR, and in 14 infants of matched
gestational age with adequate fetal growth. Infants with
IUGR had a significant decrement in intracranial vol-
ume (429.3 vs. 475.9 mL; p < 0.01) and in cerebral cor-
tical gray matter (149.3 vs. 189.0 mL; p < 0.01) at term
when compared with the control group. Besides, the
attention-interaction availability in IUGR infants was
significantly worse than that of the control group. The
authors suggested that placental insufficiency with IUGR
has adverse structural and functional effects on brain
development.
Conclusion
A large study in Europe by Karsdorp et al [29] assessed
the outcome of antenatal umbilical artery Doppler
velocimetry and indicated that the perinatal mortality
was 40% for AEDV, and even up to 70% for REDV. High-
risk pregnancies, such as preeclampsia and gestational
hypertension, have abnormal development of the pla-
centa vasculature which can be revealed in abnormal
umbilical artery Doppler velocimetry [9,28,61]. Pre-
eclampsia predisposes to the increase in vascular resis-
tance because of inadequate trophoblastic invasion of
the maternal spiral arteries, and thus diminishes uter-
oplacental perfusion which results in an increased inci-
dence of fetal hypoxia, IUGR, and even perinatal
mortality [62–64]. Thus, umbilical artery wave velocity
is an important predictor of poorer perinatal outcomes
in pregnant women with preeclampsia or hypertension
[28,61]. Furthermore, AREDV in the umbilical artery is
known to be correlated with IUGR and many neonatal
complications such as those reviewed in this article
[29]. Nevertheless, several studies revealed that when
the effects of prematurity and IUGR are taken into
consideration, AREDV in the umbilical artery appears
to be a poor indicator [31,32,49]. Larger prospective
clinical studies are required to provide adequate evi-
dence to exclude these confounding factors.
Although there are many methods of monitoring
fetal health such as the non-stress test, contraction stress
test, biophysical profile, amniotic fluid volume and
Doppler velocimetry of fetal vessels, with the current
information, we still cannot give detailed guidance to
determine the optimal timing for delivery of a preterm
infant, especially those with IUGR [65]. The challenge
for obstetricians is to balance the possibility of prema-
turity with the risk of long-term neurodevelopmental
sequelae. It has been well established that the clinical
use of umbilical artery Doppler velocimetry in high-risk
pregnancies results in a reduction of perinatal morbidity
and mortality [18,66–68]; but routine screening of
umbilical artery Doppler velocimetry in low-risk or un-
selected pregnancies reveals no benefit to mothers or
neonates [69–71]. Besides, this review is limited to dis-
cussing the effects of abnormal flow in the umbilical
artery, although other vessel flow abnormalities, such as
middle cerebral artery, aortic isthmus or ductus venosus,
are also of value.
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